Malaria: Clinical Trials

15 trials for Malaria, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 terminated. 15 Phase 2, 3 Phase 1, 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 215Terminated 15
Phase 13Terminated 3
Phase 33Terminated 3

Follow Malaria: new trials by email Literature Review of Malaria trials Research Report on Malaria

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine if New Types of Malaria Vaccines Are Safe, Effective and Lead to Immunity in Kenyan Adults
R21/Matrix-M, ChAd63/MVA ME-TRAP, intradermal injection (ID) or direct venous injection (DVI) of PfSPZ Challenge - Malaria,Falciparum
Phase 2TerminatedUniversity of Oxford802022-08-312025-02-20
Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria
artemether:lumefantrine (2.5 mg:30 mg) - Plasmodium Falciparum Malaria
Phase 2 / Phase 3TerminatedNovartis Pharmaceuticals282020-12-212026-01-13
MMV390048 POC in Patients With P. Vivax and P. Falciparum Malaria
MMV390048 - Malaria
Phase 2TerminatedMedicines for Malaria Venture82017-10-202021-12-09
Evaluation of the Safety of Primaquine in Combination With Dihydroartemisinin-piperaquine in G6PD Deficient Males in The Gambia
Dihydroartemisinin-piperaquine (DHAP) administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.25 mg/kg primaquine administered to G6PD deficient, Dihydroartemisinin-piperaquine (DHAP) + 0.4 mg/kg primaquine administered to G6PD deficient - Malaria
Phase 2 / Phase 3TerminatedLondon School of Hygiene and Tropical Medicine612015-12-012016-09-09
A Study to Characterise the Antimalarial and Transmission Blocking Activity of a Single Dose of DSM265 or OZ439 in Healthy Subjects With Induced Blood Stage Plasmodium Falciparum or Plasmodium Vivax Infection
DSM265, OZ439 - Malaria
Phase 1 / Phase 2TerminatedMedicines for Malaria Venture162015-10-012020-06-05
Eurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Eurartesim tablets - Malaria, Vivax
Phase 2TerminatedAlfasigma S.p.A.272014-06-182018-09-17
Anti-parasitic Activity and Safety Assessment of SAR97276A in Children With Uncomplicated Malaria
SAR97276A, arthemeter + lumefantrine (ACTs) - Malaria
Phase 2TerminatedSanofi202011-10-012012-12-13
Sevuparin/DF02 as an Adjunctive Therapy in Subjects Affected With Uncomplicated Falciparum Malaria
Sevuparin sodium + atovaquone/proquanil, atovaquone/proquanil - Malaria, Falciparum
Phase 1 / Phase 2TerminatedModus Therapeutics AB532011-09-012014-08-19
Phase 1/2a Trial of Pf GAP p52-/p36- Sporozoite Malaria Vaccine
p52-/p36- GAP Vaccine, p52-p36- GAP Vaccine - Malaria
Phase 1 / Phase 2TerminatedSeattle Children's Hospital62010-03-012019-10-28
Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.
SAR97276A - Malaria
Phase 2TerminatedSanofi1132008-08-012010-06-16
Azithromycin in Combination With Chloroquine Versus Chloroquine in the Eradication of Asymptomatic Plasmodium Falciparum
Azithromycin/Chloroquine, Chloroquine - Malaria, Falciparum
Phase 2TerminatedPfizer142004-08-012011-04-26
Azithromycin Plus Chloroquine Versus Sulfadoxine-Pyrimethamine Plus Chloroquine For The Treatment Of Uncomplicated, Symptomatic Falciparum Malaria In Southeast Asia
Azithromycin/Chloroquine, Sulfadoxine-Pyrimethamine/Chloroquine - Malaria, Falciparum
Phase 2 / Phase 3TerminatedPfizer322004-03-012008-11-03
Study to Evaluate the Efficacy and Safety of Tafenoquine for the Treatment of Plasmodium Vivax in Adults
Tafenoquine, Chloroquine + Primaquine, tafenoquine - Malaria, Plasmodium Vivax
Phase 2TerminatedU.S. Army Medical Research and Development Command702003-09-152018-02-23
Pentoxifylline in Children With Malaria
Pentoxifylline - Plasmodium Falciparum Malaria
Phase 2TerminatedNational Institute of Allergy and Infectious Diseases (NIAID)502002-01-012010-08-27
Cotrifazid Safety and Efficacy Against Malaria
Cotrifazid vs mefloquine or quinine+SP - Clinical Malaria
Phase 2TerminatedCenter for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland3302000-04-012006-05-08

Narrower conditions

Malaria, Falciparum (7)  ·  Malaria, Vivax (2)  ·  Lymphoma, Follicular (1)

Broader conditions

Infections (15)  ·  Mosquito-Borne Diseases (15)  ·  Parasitic Diseases (15)  ·  Protozoan Infections (15)  ·  Vector Borne Diseases (15)  ·  Hemic and Lymphatic Diseases (1)  ·  Immune System Diseases (1)  ·  Immunoproliferative Disorders (1)  ·  Lymphatic Diseases (1)  ·  Lymphoma (1)  ·  Lymphoma, Non-Hodgkin (1)  ·  Lymphoproliferative Disorders (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)

Interventions

Chloroquine (3)  ·  Azithromycin (2)  ·  Atovaquone (1)  ·  DSM265 (1)  ·  Injections, Intradermal (1)  ·  Lumefantrine (1)  ·  MMV390048 (1)  ·  Pentoxifylline (1)  ·  Primaquine (1)  ·  artefenomel (1)  ·  artenimol (1)  ·  fanasil, pyrimethamine drug combination (1)  ·  piperaquine (1)  ·  tafenoquine (1)

Sponsors

Medicines for Malaria Venture (2)  ·  Pfizer (2)  ·  Sanofi (2)  ·  Alfasigma S.p.A. (1)  ·  Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland (1)  ·  London School of Hygiene and Tropical Medicine (1)  ·  Modus Therapeutics AB (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Novartis Pharmaceuticals (1)  ·  Seattle Children's Hospital (1)  ·  U.S. Army Medical Research and Development Command (1)  ·  University of Oxford (1)

Countries

Burkina Faso (3)  ·  Kenya (3)  ·  Benin (2)  ·  Gabon (2)  ·  Thailand (2)  ·  Australia (1)  ·  Democratic Republic of the Congo (1)  ·  Ethiopia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Netherlands (1)  ·  Papua New Guinea (1)  ·  Spain (1)

Top investigators

Anna Leitgeb, PhD (1)  ·  Blaise Genton, MD, PhD (1)  ·  Christoph Hatz, Prof Dr Med (1)  ·  Esayas Gudina, MD (1)  ·  James McCarthy, Prof (1)  ·  Mezgebu Silamsaw, MD (1)  ·  Michele Spring, M.D. (1)  ·  Sornchai Looaree Suwan, MD (1)

Results publications

PMID 28472957, PMID 24029408, PMID 29121061, PMID 29244851, PMID 29324864, PMID 30269312, PMID 30858218, PMID 32479608, PMID 34179977, PMID 36509063, PMID 41199347, PMID 41495411